Generic-Drug Companies to Face First Charges in U.S. Probe

Generic-Drug Companies to Face First Charges in U.S. Probe


U.S. prosecutors are nearing their first charges against companies in an almost four-year-old criminal investigation into alleged price-fixing by generic-drug makers, according to people familiar with the matter. At least two companies are on track to be indicted in the coming months, in addition to several executives, said two people, who spoke on condition of anonymity because the investigation is confidential.



from Biotech News